FATE - Fate Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.02B
Enterprise Value 3886.37M
Trailing P/E N/A
Forward P/E 1-14.87
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)214.17
Price/Book (mrq)6.29
Enterprise Value/Revenue 3187.00
Enterprise Value/EBITDA 6-13.45

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,415.44%

Management Effectiveness

Return on Assets (ttm)-26.35%
Return on Equity (ttm)-56.04%

Income Statement

Revenue (ttm)4.74M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)61.70%
Gross Profit (ttm)-51.28M
EBITDA -65.89M
Net Income Avi to Common (ttm)-66.6M
Diluted EPS (ttm)-1.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)201.01M
Total Cash Per Share (mrq)3.09
Total Debt (mrq)14.88M
Total Debt/Equity (mrq)9.27
Current Ratio (mrq)7.53
Book Value Per Share (mrq)2.48

Cash Flow Statement

Operating Cash Flow (ttm)-38.65M
Levered Free Cash Flow (ttm)-26.45M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.03
52-Week Change 337.65%
S&P500 52-Week Change 37.08%
52 Week High 319.11
52 Week Low 38.35
50-Day Moving Average 317.02
200-Day Moving Average 315.07

Share Statistics

Avg Vol (3 month) 3646.83k
Avg Vol (10 day) 3530.09k
Shares Outstanding 565.03M
Float 52.56M
% Held by Insiders 12.29%
% Held by Institutions 196.71%
Shares Short (Mar 29, 2019) 48.3M
Short Ratio (Mar 29, 2019) 411.53
Short % of Float (Mar 29, 2019) 424.21%
Short % of Shares Outstanding (Mar 29, 2019) 412.76%
Shares Short (prior month Feb 28, 2019) 48.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A